201 related articles for article (PubMed ID: 36766845)
1. Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.
Mészáros M; Phan THM; Vigh JP; Porkoláb G; Kocsis A; Páli EK; Polgár TF; Walter FR; Bolognin S; Schwamborn JC; Jan JS; Deli MA; Veszelka S
Cells; 2023 Feb; 12(3):. PubMed ID: 36766845
[TBL] [Abstract][Full Text] [Related]
2. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
3. A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model.
Veszelka S; Mészáros M; Porkoláb G; Szecskó A; Kondor N; Ferenc G; Polgár TF; Katona G; Kóta Z; Kelemen L; Páli T; Vigh JP; Walter FR; Bolognin S; Schwamborn JC; Jan JS; Deli MA
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056983
[TBL] [Abstract][Full Text] [Related]
4. Combination of Alanine and Glutathione as Targeting Ligands of Nanoparticles Enhances Cargo Delivery into the Cells of the Neurovascular Unit.
Porkoláb G; Mészáros M; Tóth A; Szecskó A; Harazin A; Szegletes Z; Ferenc G; Blastyák A; Mátés L; Rákhely G; Deli MA; Veszelka S
Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32645904
[TBL] [Abstract][Full Text] [Related]
5. Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells.
Veszelka S; Meszaros M; Kiss L; Kota Z; Pali T; Hoyk Z; Bozso Z; Fulop L; Toth A; Rakhely G; Deli MA
Curr Pharm Des; 2017; 23(28):4198-4205. PubMed ID: 28748755
[TBL] [Abstract][Full Text] [Related]
6. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
[TBL] [Abstract][Full Text] [Related]
7. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
8. Crossing the blood-brain barrier with nanoparticles.
Zhou Y; Peng Z; Seven ES; Leblanc RM
J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
[TBL] [Abstract][Full Text] [Related]
9. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
[TBL] [Abstract][Full Text] [Related]
10. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
[TBL] [Abstract][Full Text] [Related]
11. The presence of BBB hastens neuronal differentiation of cerebral organoids - The potential role of endothelial derived BDNF.
Fedele G; Cazzaniga A; Castiglioni S; Locatelli L; Tosoni A; Nebuloni M; Maier JAM
Biochem Biophys Res Commun; 2022 Oct; 626():30-37. PubMed ID: 35970042
[TBL] [Abstract][Full Text] [Related]
12. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics.
Bergmann S; Lawler SE; Qu Y; Fadzen CM; Wolfe JM; Regan MS; Pentelute BL; Agar NYR; Cho CF
Nat Protoc; 2018 Dec; 13(12):2827-2843. PubMed ID: 30382243
[TBL] [Abstract][Full Text] [Related]
14. ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood-Brain Barrier.
Topal GR; Mészáros M; Porkoláb G; Szecskó A; Polgár TF; Siklós L; Deli MA; Veszelka S; Bozkir A
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33383743
[TBL] [Abstract][Full Text] [Related]
15. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
16. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Kuo YC; Yu HW
Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
[TBL] [Abstract][Full Text] [Related]
17. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
Zhao X; Ye Y; Ge S; Sun P; Yu P
Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
[TBL] [Abstract][Full Text] [Related]
18. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
19. The Inclusion of a Matrix Metalloproteinase-9 Responsive Sequence in Self-assembled Peptide-based Brain-Targeting Nanoparticles Improves the Efficiency of Nanoparticles Crossing the Blood-Brain Barrier at Elevated MMP-9 Levels.
Islam Y; Ehtezazi P; Cashmore A; Marinsalda E; Leach AG; Coxon CR; Fatokun AA; Sexton DW; Khan I; Zouganelis G; Downing J; Pluchino S; Sivakumaran M; Teixido M; Ehtezazi T
J Pharm Sci; 2021 Mar; 110(3):1349-1364. PubMed ID: 33333144
[TBL] [Abstract][Full Text] [Related]
20. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]